AORT PEER ANALYSIS

Artivion Inc — metric-by-metric comparison with peers and the industry median

AORTArtivion Inc

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

AORTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	AORT	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
P/E	101.97	—	23.72	20.56●	122.41	596.83	27.44
P/B	2.65	-74.16●	4.23	2.48	13.36	1.08	2.48
EV/EBITDA	21.44	—	14.87	9.88●	25.46	10.93	15.23
P/S	2.60	243.16	3.47	2.09	7.66	1.18●	2.66

Financial Health
Metric	AORT	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Current Ratio	3.28	6.57●	2.46	2.57	2.25	3.58	3.28
Debt/Equity	57.3%	-22.6%●	22.1%	62.9%	35.0%	1.0%	44.7%
NetDebt/EBITDA	3.11	0.71	0.42	1.72	0.42	-1.64●	0.82

Profitability
Metric	AORT	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Net Margin	2.5%	-3,684.6%	14.6%●	10.1%	6.3%	0.2%	-5.7%
ROE	3.1%	—	18.1%●	12.1%	12.9%	0.2%	-8.6%
ROA	1.4%	-264.3%	12.4%●	6.1%	8.0%	0.2%	-6.4%
EBITDA Margin	14.2%	-818.8%	24.0%	25.6%	30.6%●	9.4%	5.2%

Growth + Dividend
Metric	AORT	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Rev. Growth	17.6%	-26.0%	2.0%	—	39.1%●	6.5%	7.4%
NI Growth	—	—	-6.8%●	—	—	-62.9%	16.7%
Div. Yield	—	—	3.6%●	3.5%	0.0%	1.1%	1.1%
Payout	—	—	81.5%	52.8%	0.0%	656.3%	39.0%

Valuation
Metric	AORT	PRCT	AVNS	QDEL	ENOV	IRMD	Ind. Median
P/E	101.97	—	—	—	—	55.04●	27.44
P/B	2.65	3.42	1.48	0.67●	0.87	13.19	2.48
EV/EBITDA	21.44	—	—	—	—	—	15.23
P/S	2.60	3.69	1.62	0.47●	0.56	15.06	2.66

Financial Health
Metric	AORT	PRCT	AVNS	QDEL	ENOV	IRMD	Ind. Median
Current Ratio	3.28	6.73	2.48	1.43	2.04	7.13●	3.28
Debt/Equity	57.3%	14.9%●	17.7%	155.3%	95.5%	—	44.7%
NetDebt/EBITDA	3.11	2.11	-3.37	-4.98●	-1.84	—	0.82

Profitability
Metric	AORT	PRCT	AVNS	QDEL	ENOV	IRMD	Ind. Median
Net Margin	2.5%	-31.8%	-9.7%	-45.6%	-49.9%	27.4%●	-5.7%
ROE	3.1%	-27.8%	-8.6%	-49.9%	-55.5%	25.0%●	-8.6%
ROA	1.4%	-20.4%	-6.4%	-20.0%	-26.1%	21.8%●	-6.4%
EBITDA Margin	14.2%	-28.6%	-3.0%	-20.7%	-32.8%	37.4%●	5.2%

Growth + Dividend
Metric	AORT	PRCT	AVNS	QDEL	ENOV	IRMD	Ind. Median
Rev. Growth	17.6%	29.3%●	3.9%	-3.9%	6.0%	14.8%	7.4%
NI Growth	—	—	—	—	—	19.3%	16.7%
Div. Yield	—	—	—	—	—	0.8%	1.1%
Payout	—	—	—	—	—	65.4%	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AORT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.